Literature DB >> 31461736

Prevalence and Risk Factors of HIV-Associated Neurocognitive Disorders in Rural Southwestern Uganda.

Jane Kasozi Namagga, Godfrey Zari Rukundo, Joachim G Voss.   

Abstract

Advances in treatment of HIV have dramatically improved survival rates; HIV-associated neurocognitive disorders (HAND), however, remain highly prevalent and continue to represent a significant public health problem, especially in resource-limited settings. We completed a cross-sectional study to describe the prevalence and risk factors for HAND in rural Southwestern Uganda AIDS Support Organization Centers. After securing ethical clearance from relevant bodies, 393 participants were screened for HAND using the International HIV Dementia Scale. A cutoff score of ≤10 and a significance level of p ≤ .05 were set. More than half of the 393 participants (n = 229, 58.23%) screened positive for HAND. The associated risk factors were gender (odds ratio [OR] 0.54, p = .017), peasant farming (OR 1.70, p = .04), and older age (OR 1.03, p = .019). HIV-associated neurocognitive disorder remains one of the major complications of HIV despite improvement in antiretroviral therapy and life expectancies.

Entities:  

Year:  2019        PMID: 31461736      PMCID: PMC6716529          DOI: 10.1097/JNC.0000000000000036

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  35 in total

1.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

2.  HIV-related neurological syndromes reduce health-related quality of life.

Authors:  Rupang Pandya; Hartmut B Krentz; M John Gill; Christopher Power
Journal:  Can J Neurol Sci       Date:  2005-05       Impact factor: 2.104

3.  Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care.

Authors:  Helen Yeung; Hartmut B Krentz; M John Gill; Christopher Power
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

4.  Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.

Authors:  Valerio Tozzi; Pietro Balestra; Patrizia Lorenzini; Rita Bellagamba; Simonetta Galgani; Angela Corpolongo; Chrysoula Vlassi; Dora Larussa; Mauro Zaccarelli; Pasquale Noto; Ubaldo Visco-Comandini; Marinella Giulianelli; Giuseppe Ippolito; Andrea Antinori; Pasquale Narciso
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

5.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

Review 6.  Neurological complications of HIV infection.

Authors:  Justin C McArthur; Bruce J Brew; Avi Nath
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

7.  The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.

Authors:  Alfred K Njamnshi; Vincent de Paul Djientcheu; Julius Y Fonsah; Faustin N Yepnjio; Dora M Njamnshi; Walinjom E Muna
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

8.  The prevalence and incidence of neurocognitive impairment in the HAART era.

Authors:  Kevin R Robertson; Marlene Smurzynski; Thomas D Parsons; Kunling Wu; Ronald J Bosch; Julia Wu; Justin C McArthur; Ann C Collier; Scott R Evans; Ron J Ellis
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

9.  Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.

Authors:  V Valcour; C Shikuma; B Shiramizu; M Watters; P Poff; O Selnes; P Holck; J Grove; N Sacktor
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

10.  No gender differences in the progression of nervous system disease in HIV infection.

Authors:  Kevin R Robertson; Catherine Kapoor; Wendy T Robertson; Susan Fiscus; Sutapa Ford; Colin D Hall
Journal:  J Acquir Immune Defic Syndr       Date:  2004-07-01       Impact factor: 3.731

View more
  4 in total

1.  Mbarara University Research Training Initiative: Experiences and Accomplishments of the MEPI Junior D43 TW010128 Award in Uganda.

Authors:  Edith K Wakida; Clara D Atuhaire; Christine K Karungi; Samuel Maling; Celestino Obua
Journal:  Adv Med Educ Pract       Date:  2021-12-03

2.  Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers.

Authors:  Giulia Caligaris; Mattia Trunfio; Valeria Ghisetti; Jessica Cusato; Marco Nigra; Cristiana Atzori; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  Diagnostics (Basel)       Date:  2021-05-12

Review 3.  The Role of Brain Derived Neurotrophic Factor in HIV-Associated Neurocognitive Disorder: From the Bench-Top to the Bedside.

Authors:  Henry Michael; Thabisile Mpofana; Suvira Ramlall; Frasia Oosthuizen
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-31       Impact factor: 2.570

4.  Prevalence of Severe Neurocognitive Impairment and Its Association with Socio-Demographics and Functionality Among Ugandan Older Persons: A Hospital-Based Study.

Authors:  Letizia Maria Atim; Mark Mohan Kaggwa; Mohammed A Mamun; Scholastic Ashaba; Samuel Maling
Journal:  Clin Interv Aging       Date:  2021-07-22       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.